| Cat.# |
CB0368
|
| Size |
60
µg / 200 ml |
| Isotype:
|
mouse
monoclonal IgG1
|
| Epitope: |
Sf9 cell-expressed recombinant human
c-Src
proteins. |
| Specificity
& sensitivity: |
human, mouse, rat, monkey
(This antibody specifically detects endogenous
levels of Src proteins. This antibody does not cross-react with
other Src-family members by Western blot analysis using specific
recombinant proteins.)
|
| Storage: |
-20°
|
| MW:
|
60
kDa
|
|
Application:
|
WB
|
| Dilution:
|
1:1000
|
|
Background:
Src
was the first protooncogene described and was among the first molecules
in which tyrosine kinase activity was documented.
The
Src gene family has nine known members (Blk, c-Fgr, Fyn, Hck, Lck, Lyn,
c-Src, c-Yes and Yrk), each encoding a cytoplasmic protein-tyrosine
kinase (PTK) believed to be involved in signal transduction. The Src
PTKs contain three domains (SH1, SH2 and SH3) that are found in many
other signalling proteins. The SH1 domain has PTK activity, whilst the
SH2 and SH3 domains are involved in mediating protein-protein
interactions by binding to phosphotyrosine-containing and proline-rich
motifs, respectively. The expression patterns of the c-Src PTKs suggest
that they function in a broad range of biological situations, in many
cases regulating the behaviour of terminally-differentiated,
post-mitotic cell types1. Src
has been defined as a common modular structure that participates in much
of the crosstalk between the cytoplasmic protein tyrosine kinases and
tyrosine kinase receptors2. Src
has been found to be overexpressed and activated in a large number of
different cancers. Cellular Src has been shown to activate a number of
different effectors that are involved in different aspects of cancer
biology such as metastasis, cell cycle regulation and cell survival3,
4. Cumulative data mark Src signaling as attractive therapeutic
targets in different cancers.
References:
1.
Homsi,
J. et al., Expert Opin Ther Targets. 11:91-100, 2007.
2.
Brickell, P. M. et al., Crit Rev Oncog 3:401, 1993.
3.
Bolen, J. B. et al., FASEB J 6:3403, 1992.
4.
Alvarez, R. H. et al., Cancer 107:1918, 2006.
|
|

Various
cell lysates were subjected for Western blot analysis using Src (10H4)
monoclonal antibody. A 60 kDa Src protein band was specifically detected
in all cell lysates.
|